|
| |
| | | 57460 | | 22.11.2007 | | Future Health Pharma GmbH | | | | | | | | | | | | | 01.01.30. | | | | 01.01.30. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Matrifen 25 ug/h | Transdermales Pflaster | Transdermal System (Fentanyl 2.75 mg) | N02AB03 | CI | | 02 | Matrifen 50 ug/h | Transdermales Pflaster | Transdermal System (Fentanyl 5.5 mg) | N02AB03 | CI | | 03 | Matrifen 75 ug/h | Transdermales Pflaster | Transdermal System (Fentanyl 8.25 mg) | N02AB03 | CI | | 04 | Matrifen 100 ug/h | Transdermales Pflaster | Transdermal System (Fentanyl 11 mg) | N02AB03 | CI | | 05 | Matrifen 12 ug/h | Transdermales Pflaster | Transdermal System (Fentanyl 1.38 mg) | N02AB03 | CI |
|
|
|
